Therefore, since acetylation is crucial for p53’s antiproliferative and pro-apoptotic functions, the loss or mutation of its acetyltransferases in cancer underscores the importance of CBP and p300 in modulating this pathway, making their role particularly relevant for therapeutic intervention. Here, EP300 is linked to cancer.